Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age-Reference-Cited by-同舟云学术

Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age

Published:2021-07-30 Issue:30 Volume:100 Page:e26711
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Kim Su Jin,Kim Min-Sun,Cho Sung Yoon,Suh Byung-Kyu,Ko Cheol Woo,Lee Kee-Hyoung,Yoo Han-Wook,Shin Choong Ho,Hwang Jin Soon,Kim Ho-Seong,Chung Woo Yeong,Kim Chan Jong,Han Heon-Seok,Jin Dong-Kyu

Funder

Dong-A ST Co., Ltd., Seoul, Republic of Korea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference25 articles.

1. Short children born small for gestational age outcomes in the era of growth hormone therapy;Zanelli;Growth Horm IGF Res,2018

2. Longitudinal follow-up of height up to five years of age in infants born preterm small for gestational age; comparison to full-term small for gestational age infants;Itabashi;Early Hum Dev,2007

3. Growth in full-term small-for-gestational-age infants: from birth to final height;Karlberg;Pediatr Res,1995

4. Small for gestational age: short stature and beyond;Saenger;Endocr Rev,2007

5. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis;Cutfield;Horm Res,2006

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Difficulties in Interpreting IGF-1 Levels in Short Stature Children Born Small for Gestational Age (SGA) Treated with Recombinant Human Growth Hormone (rhGH) Based on Data from Six Clinical Centers in Poland;Journal of Clinical Medicine;2023-06-29